File(s) not publicly available
CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort
journal contribution
posted on 2023-02-16, 03:37 authored by Anadil Javaid, Sheau Wen Lok, Vanessa Wong, Sally Baron-Hay, Fran Boyle, Ian CollinsIan Collins, Katharine Cuff, Richard de Boer, Lucy Gately, Chloe Georgiou, Sally Greenberg, Bhaskar Karki, Michelle Nottage, Natalie Rainey, Javier Torres, Belinda Yeo, Bianca Devitt, Peter Gibbs, Angelyn AntonCDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort
